FDA Blood Platelet Research Internship
*Applications will be reviewed on a rolling-basis.
A research opportunity is currently available in the Office of Blood Research and Review (OBRR), at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
The research project is focused on cellular and molecular aspects of new methods of long term storage of blood platelets for transfusion.
The participant will gain theoretical knowledge in platelet biology and platelet transfusion science, including current methods of platelet processing and storage and needs for long term platelet storage. The participant will gain theoretical knowledge and practical experience in laboratory assays for evaluation of quality of platelets for transfusion, characterization of platelet membrane vesicles, and other membrane changes in platelets stored for transfusion and new methods of platelet cryopreservation.
Anticipated Appointment Start Date: September 1, 2020
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for nine months, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Qualifications
The qualified candidate should have received a bachelor's degree in one of the relevant fields, or be currently pursuing the degree and will reach completion by the appointment start date. Degree must have been received within five years of the appointment start date.
This opportunity is available to US citizens and Lawful Permanent Residents (LPR) only.
If you have questions, send an email to ORISE.FDA.CBER@orau.org. Please include the reference code for this opportunity (FDA-CBER-2020-0054) in your email.